Latest stock market podcasts

Bell Direct

March 20, 2026

In this episode of From the Helm, Grady chats with Alterity Therapeutics (ASX:ATH) CEO David Stamler, to discuss their neurodegenerative disorder treatment specifically targeting Multiple System Atrophy (MSA), a rare and aggressive disease affecting involuntary functions and motor control.

Weekly Wrap 5 June

Bell Direct

June 5, 2026

Weekly Wrap 22 May

Bell Direct

May 22, 2026

Weekly Wrap 15 May

Bell Direct

May 15, 2026

From the helm: Solstice Minerals (ASX:SLS), Managing Director and CEO Nick Castleden

Bell Direct

May 15, 2026

Weekly Wrap 8 May

Bell Direct

May 8, 2026

Weekly Wrap 1 May

Bell Direct

May 1, 2026

Weekly Wrap 24 April

Bell Direct

April 24, 2026

Weekly Wrap 17 April

Bell Direct

April 17, 2026

From the helm: Centaurus Metals (ASX:CTM), CEO & MD, Darren Gordon

Bell Direct

April 2, 2026

From the helm: Oneview Healthcare (ASX:ONE), CEO, James Fitter

Bell Direct

April 2, 2026

From the helm: Titomic Ltd, CFO, Geoff Hollis

Bell Direct

April 1, 2026

From the helm: Artrya Limited (ASX:AYA): John Konstantopoulos, CEO & Co-Founder

Bell Direct

April 1, 2026